Home >> Tag Archives: HTG Molecular Diagnostics—

Tag Archives: HTG Molecular Diagnostics—

Validation of blood test for heart transplant rejection, 12/13

December 2013—The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and HTG Molecular Diagnostics are collaborating to begin clinical validation of a biomarker blood test that will provide early indication of organ rejection in heart transplant patients and thereby allow doctors to better monitor and treat patients post-transplant. It is the first clinical validation study of this kind in Canada.

Read More »